BioCentury
ARTICLE | Clinical News

Cytori Cell Therapy: Phase II start

January 20, 2014 8:00 AM UTC

This quarter, Cytori will begin the open-label, U.S. Phase II RECOVER trial to evaluate single doses of up to 20 or 40 million cells of Cytori Cell Therapy in 10 patients with Grade II tears of the ha...